Search research articles
Contact Us
Filters
Showing results (71-80 of 104) with videos related to
Page
of 11
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 9, 2020
Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro
Tesia Bobrowski, Lu Chen, Richard T Eastman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 17, 2020
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
Tesia Bobrowski, Lu Chen, Richard T Eastman, et al.
Mbio
|
March 12, 2015
Regulation of Plasmodium yoelii oocyst development by strain- and stage-specific small-subunit rRNA
Yanwei Qi, Feng Zhu, Richard T Eastman, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2023
A Plasmodium falciparum RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses
Brajesh K Singh, Cui Zhang, Jian Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2011
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue
Sophie H Adjalley, Geoffrey L Johnston, Tao Li, et al.
Journal of Medicinal Chemistry
|
September 19, 2003
Oxidosqualene cyclase inhibitors as antimicrobial agents
Jerald C Hinshaw, Dae-Yeon Suh, Philippe Garnier, et al.
ACS Pharmacology & Translational Science
|
May 18, 2023
Quantitative Bioactivity Signatures of Dietary Supplements and Natural Products
Adam Yasgar, Danielle Bougie, Richard T Eastman, et al.
Cell
|
August 16, 2014
Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate
Andreas Martin Lisewski, Joel P Quiros, Caroline L Ng, et al.
Genes and Immunity
|
January 24, 2014
Plasmodium genetic loci linked to host cytokine and chemokine responses
S Pattaradilokrat, J Li, J Wu, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 <i>in vitro</i> activity
Richard T Eastman, Radda Rusinova, Karl F Herold, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 104) with videos related to
Sort By:
Page
of 11
Biorxiv : the Preprint Server for Biology
|
July 9, 2020
Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro
Tesia Bobrowski, Lu Chen, Richard T Eastman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 17, 2020
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
Tesia Bobrowski, Lu Chen, Richard T Eastman, et al.
Mbio
|
March 12, 2015
Regulation of Plasmodium yoelii oocyst development by strain- and stage-specific small-subunit rRNA
Yanwei Qi, Feng Zhu, Richard T Eastman, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2023
A Plasmodium falciparum RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses
Brajesh K Singh, Cui Zhang, Jian Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2011
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue
Sophie H Adjalley, Geoffrey L Johnston, Tao Li, et al.
Journal of Medicinal Chemistry
|
September 19, 2003
Oxidosqualene cyclase inhibitors as antimicrobial agents
Jerald C Hinshaw, Dae-Yeon Suh, Philippe Garnier, et al.
ACS Pharmacology & Translational Science
|
May 18, 2023
Quantitative Bioactivity Signatures of Dietary Supplements and Natural Products
Adam Yasgar, Danielle Bougie, Richard T Eastman, et al.
Cell
|
August 16, 2014
Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate
Andreas Martin Lisewski, Joel P Quiros, Caroline L Ng, et al.
Genes and Immunity
|
January 24, 2014
Plasmodium genetic loci linked to host cytokine and chemokine responses
S Pattaradilokrat, J Li, J Wu, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 <i>in vitro</i> activity
Richard T Eastman, Radda Rusinova, Karl F Herold, et al.
Page
of 11